Biotech, SECVERAXA Biotech, Voyager Acquisition File SEC Forms for $1.64B Merger Expected Q4 2025100% left coverage2 sources
Biotech, SECVERAXA Biotech, Voyager Acquisition File SEC Forms for $1.64B Merger Expected Q4 2025100% left coverage2 sources
Biotech, BiotechnologyNKGen Biotech, HekaBio Partner to Develop NK Cell Therapy in Japan100% left coverage1 source
Biotech, BiotechnologyNKGen Biotech, HekaBio Partner to Develop NK Cell Therapy in Japan100% left coverage1 source
Biotech, MarketsFDA Approves 127 Innovative, Biosimilar Drugs in 2024 Amid Global Pharma Shift100% right coverage1 source
Biotech, MarketsFDA Approves 127 Innovative, Biosimilar Drugs in 2024 Amid Global Pharma Shift100% right coverage1 source
BiotechPDS Biotech Expands Phase 2 Colorectal Cancer Trial After Positive Results100% left coverage1 source
BiotechPDS Biotech Expands Phase 2 Colorectal Cancer Trial After Positive Results100% left coverage1 source
BiotechTrinity Biotech Achieves Profitability Milestone After Restructuring100% left coverage1 source
BiotechTrinity Biotech Achieves Profitability Milestone After Restructuring100% left coverage1 source
Biotech, European UnionEU Pharma Leaders Push European Nasdaq, Innovation Reforms to Boost Biotech100% left coverage1 source
Biotech, European UnionEU Pharma Leaders Push European Nasdaq, Innovation Reforms to Boost Biotech100% left coverage1 source